메뉴 건너뛰기




Volumn 6, Issue 3, 2015, Pages 270-275

Amplification of chromosome 8 genes in lung cancer

Author keywords

Copy number changes; Lung cancer; Oncogenes

Indexed keywords

ADAM9 PROTEIN; AURORA A KINASE; C11ORF30 PROTEIN; CARBOXYPEPTIDASE D; CELL CYCLE PROTEIN 6; CYCLIN D1; CYCLIN E; CYCLIN E1; DNA TOPOISOMERASE (ATP HYDROLYSING); EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR ALPHA; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIZZY RELATED PROTEIN; I KAPPA B KINASE BETA; METADHERIN PROTEIN; MYC PROTEIN; PEPTIDES AND PROTEINS; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING PROTEIN; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN PHOSPHATASE 1D; SURVIVIN; TAU PROTEIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN 703;

EID: 84923689907     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.10638     Document Type: Article
Times cited : (36)

References (49)
  • 3
    • 43949091796 scopus 로고    scopus 로고
    • Lung cancer epigenetics and genetics
    • Risch A, Plass C. Lung cancer epigenetics and genetics. Int J Cancer. 2008; 123: 1-7.
    • (2008) Int J Cancer , vol.123 , pp. 1-7
    • Risch, A.1    Plass, C.2
  • 5
    • 0033591845 scopus 로고    scopus 로고
    • Tobacco smoke carcinogens and lung cancer
    • Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst. 1999; 91: 1194-1210.
    • (1999) J Natl Cancer Inst , vol.91 , pp. 1194-1210
    • Hecht, S.S.1
  • 6
    • 4444344330 scopus 로고    scopus 로고
    • EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib
    • Pao W, Miller V, Zakowski M, et al. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA. 2004; 101: 13306-13311.
    • (2004) Proc Natl Acad Sci USA , vol.101 , pp. 13306-13311
    • Pao, W.1    Miller, V.2    Zakowski, M.3
  • 7
    • 2342624080 scopus 로고    scopus 로고
    • EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy
    • Paez JG, Jänne PA, Lee JC, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science. 2004; 304: 1497-1500.
    • (2004) Science , vol.304 , pp. 1497-1500
    • Paez, J.G.1    Jänne, P.A.2    Lee, J.C.3
  • 8
    • 2342471392 scopus 로고    scopus 로고
    • Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
    • Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med. 2004; 350: 2129-2139.
    • (2004) N Engl J Med , vol.350 , pp. 2129-2139
    • Lynch, T.J.1    Bell, D.W.2    Sordella, R.3
  • 9
    • 13844317894 scopus 로고    scopus 로고
    • EGFR mutation and resistance of non-small-cell lung cancer to gefitinib
    • Kobayashi S, Boggon TJ, Dayaram T, et al. EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. N Engl J Med. 2005; 352: 786-792.
    • (2005) N Engl J Med , vol.352 , pp. 786-792
    • Kobayashi, S.1    Boggon, T.J.2    Dayaram, T.3
  • 10
    • 18244371651 scopus 로고    scopus 로고
    • Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain
    • Pao W, Miller VA, Politi KA, et al. Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain. PLos Med. 2005; 2: e73.
    • (2005) PLos Med , vol.2
    • Pao, W.1    Miller, V.A.2    Politi, K.A.3
  • 11
    • 20444480258 scopus 로고    scopus 로고
    • TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers
    • Le Calvez F, Mukeria A, Hunt JD, et al. TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers. Cancer Res. 2005; 65: 5076-5083.
    • (2005) Cancer Res , vol.65 , pp. 5076-5083
    • Le Calvez, F.1    Mukeria, A.2    Hunt, J.D.3
  • 12
    • 15744372810 scopus 로고    scopus 로고
    • KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib
    • Pao W, Wang TY, Riely GJ, et al. KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib. PLoS Med. 2005; 2: e17.
    • (2005) PLoS Med , vol.2
    • Pao, W.1    Wang, T.Y.2    Riely, G.J.3
  • 13
    • 54549094903 scopus 로고    scopus 로고
    • Somatic mutations affect key pathways in lung adenocarcinoma
    • Ding L, Getz G, Wheeler DA, et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature. 2008; 455: 1069-1075.
    • (2008) Nature , vol.455 , pp. 1069-1075
    • Ding, L.1    Getz, G.2    Wheeler, D.A.3
  • 14
    • 21344437734 scopus 로고    scopus 로고
    • Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis
    • Zhao X, Weir BA, LaFramboise T, et al. Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis. Cancer Res. 2005; 65: 5561-5570.
    • (2005) Cancer Res , vol.65 , pp. 5561-5570
    • Zhao, X.1    Weir, B.A.2    LaFramboise, T.3
  • 15
    • 33845191779 scopus 로고    scopus 로고
    • Genomic and transcriptional aberrations linked to breast cancer pathophysiologies
    • Chin K, DeVries S, Fridlyand J, et al. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell. 2006; 10: 529-541.
    • (2006) Cancer Cell , vol.10 , pp. 529-541
    • Chin, K.1    DeVries, S.2    Fridlyand, J.3
  • 16
    • 79953737554 scopus 로고    scopus 로고
    • A new treasure in breast cancer gene hunt
    • Spellman P, Gray J. A new treasure in breast cancer gene hunt. Nat Med. 2011; 17: 422-423.
    • (2011) Nat Med , vol.17 , pp. 422-423
    • Spellman, P.1    Gray, J.2
  • 17
    • 3543023204 scopus 로고    scopus 로고
    • Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification
    • Schouten JP, McElgunn CJ, Waaijer R, et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 2002; 30: e57.
    • (2002) Nucleic Acids Res , vol.30
    • Schouten, J.P.1    McElgunn, C.J.2    Waaijer, R.3
  • 18
    • 1642286979 scopus 로고    scopus 로고
    • Chromosomal analysis of non-small-cell lung cancer by multicolor fluorescent in situ hybridization
    • Berrieman HK, Ashman JN, Cowen ME, et al. Chromosomal analysis of non-small-cell lung cancer by multicolor fluorescent in situ hybridization. Br J Cancer. 2004; 90: 900-5.
    • (2004) Br J Cancer , vol.90 , pp. 900-905
    • Berrieman, H.K.1    Ashman, J.N.2    Cowen, M.E.3
  • 19
    • 0035026584 scopus 로고    scopus 로고
    • Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization
    • Luk C, Tsao MS, Bayani J, Shepherd F, Squire JA. Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization. Cancer Genet Cytogenet. 2001; 125: 87-99.
    • (2001) Cancer Genet Cytogenet , vol.125 , pp. 87-99
    • Luk, C.1    Tsao, M.S.2    Bayani, J.3    Shepherd, F.4    Squire, J.A.5
  • 20
    • 0344734060 scopus 로고    scopus 로고
    • DNA gains in 3q occur frequently in squamous cell carcinoma of the lung, but not in adenocarcinoma
    • Björkqvist AM, Husgafvel-Pursiainen K, Anttila S, et al. DNA gains in 3q occur frequently in squamous cell carcinoma of the lung, but not in adenocarcinoma. Genes Chromosomes Cancer. 1998; 22: 79-82.
    • (1998) Genes Chromosomes Cancer , vol.22 , pp. 79-82
    • Björkqvist, A.M.1    Husgafvel-Pursiainen, K.2    Anttila, S.3
  • 21
    • 0026495364 scopus 로고
    • Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors
    • Kallioniemi A, Kallioniemi OP, Sudar D, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science. 1992; 258: 818-821.
    • (1992) Science , vol.258 , pp. 818-821
    • Kallioniemi, A.1    Kallioniemi, O.P.2    Sudar, D.3
  • 22
    • 0031442680 scopus 로고    scopus 로고
    • Detailed deletion mapping at chromosome 9p21 in non-small cell lung cancer by microsatellite analysis and fluorescence in situ hybridization
    • Okami K, Cairns P, Westra WH, et al. Detailed deletion mapping at chromosome 9p21 in non-small cell lung cancer by microsatellite analysis and fluorescence in situ hybridization. Int J Cancer. 1997; 74: 588-592.
    • (1997) Int J Cancer , vol.74 , pp. 588-592
    • Okami, K.1    Cairns, P.2    Westra, W.H.3
  • 23
    • 36248980204 scopus 로고    scopus 로고
    • Characterizing the cancer genome in lung adenocarcinoma
    • Weis BA, Woo MS, Getz G, et al. Characterizing the cancer genome in lung adenocarcinoma. Nature. 2007; 450: 893-898.
    • (2007) Nature , vol.450 , pp. 893-898
    • Weis, B.A.1    Woo, M.S.2    Getz, G.3
  • 24
    • 28544431712 scopus 로고    scopus 로고
    • Genome-wide screening of genomic alterations and their clinicopathologic implications in non-small cell lung cancers
    • Kim TM, Yim SH, Lee JS, et al. Genome-wide screening of genomic alterations and their clinicopathologic implications in non-small cell lung cancers. Clin Cancer Res. 2005; 11: 8235-8242.
    • (2005) Clin Cancer Res , vol.11 , pp. 8235-8242
    • Kim, T.M.1    Yim, S.H.2    Lee, J.S.3
  • 25
    • 77957896015 scopus 로고    scopus 로고
    • Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer
    • Castro M, Grau L, Puerta P, et al. Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer. J Transl Med. 2010; 8: 86.
    • (2010) J Transl Med , vol.8 , pp. 86
    • Castro, M.1    Grau, L.2    Puerta, P.3
  • 26
    • 84923682707 scopus 로고    scopus 로고
    • Mitelman database of chromosome aberrations and gene fusions in cancer
    • Mitelman F, Johansson B, Mertens F. Mitelman database of chromosome aberrations and gene fusions in cancer; 2009. http://cgap.nci.nih.gov/Chromosomes/Mitelman
    • (2009)
    • Mitelman, F.1    Johansson, B.2    Mertens, F.3
  • 27
    • 0033109539 scopus 로고    scopus 로고
    • Chromosome 8 copy numbers and the c-myc gene amplification in non-small cell lung cancer. Analysis by interphase cytogenetics
    • Kubokura H, Koizumi K, Yamamoto M, Tanaka S. Chromosome 8 copy numbers and the c-myc gene amplification in non-small cell lung cancer. Analysis by interphase cytogenetics. Nihon Ika Daigaku Zasshi. 1999; 66: 107-112.
    • (1999) Nihon Ika Daigaku Zasshi , vol.66 , pp. 107-112
    • Kubokura, H.1    Koizumi, K.2    Yamamoto, M.3    Tanaka, S.4
  • 28
    • 79952078260 scopus 로고    scopus 로고
    • ZNF703 gene amplification at 8p12 specifies luminal B breast cancer
    • Sircoulomb F, Nicolas N, Ferrari A, et al. ZNF703 gene amplification at 8p12 specifies luminal B breast cancer. EMBO Mol Med. 2011; 3: 153-166.
    • (2011) EMBO Mol Med , vol.3 , pp. 153-166
    • Sircoulomb, F.1    Nicolas, N.2    Ferrari, A.3
  • 29
    • 79952093026 scopus 로고    scopus 로고
    • ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium
    • Holland DG, Burleigh A, Git A, et al. ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium. EMBO Mol Med. 2011; 3: 167-180.
    • (2011) EMBO Mol Med , vol.3 , pp. 167-180
    • Holland, D.G.1    Burleigh, A.2    Git, A.3
  • 30
    • 84883159846 scopus 로고    scopus 로고
    • Luminal breast cancer cell lines overexpressing ZNF703 are resistant to tamoxifen through activation of Akt/mTOR signaling
    • Zhang X, Mu X, Huang O, et al. Luminal breast cancer cell lines overexpressing ZNF703 are resistant to tamoxifen through activation of Akt/mTOR signaling. PLoS One. 2013; 8: e72053.
    • (2013) PLoS One , vol.8
    • Zhang, X.1    Mu, X.2    Huang, O.3
  • 31
    • 84904300249 scopus 로고    scopus 로고
    • ZNF703 acts as an oncogene that promotes progression in gastric cancer
    • Yang G, Ma F, Zhang M, et al. ZNF703 acts as an oncogene that promotes progression in gastric cancer. Oncol Rep. 2014; 31: 1877-1882.
    • (2014) Oncol Rep , vol.31 , pp. 1877-1882
    • Yang, G.1    Ma, F.2    Zhang, M.3
  • 32
    • 84923068533 scopus 로고    scopus 로고
    • ZNF703 promotes tumor cell proliferation and invasion and predicts poor prognosis in patients with colorectal cancer
    • Ma F, Bi L, Yang G, et al. ZNF703 promotes tumor cell proliferation and invasion and predicts poor prognosis in patients with colorectal cancer. Oncol Rep. 2014; 32: 1071-1077.
    • (2014) Oncol Rep , vol.32 , pp. 1071-1077
    • Ma, F.1    Bi, L.2    Yang, G.3
  • 33
    • 84902110153 scopus 로고    scopus 로고
    • High expression of ZNF703 independent of amplification indicates worse prognosis in patients with luminal B breast cancer
    • Reynisdottir I, Arason A, Einarsdottir BO, et al. High expression of ZNF703 independent of amplification indicates worse prognosis in patients with luminal B breast cancer. Cancer Med. 2013; 2: 437-446.
    • (2013) Cancer Med , vol.2 , pp. 437-446
    • Reynisdottir, I.1    Arason, A.2    Einarsdottir, B.O.3
  • 34
    • 79952093753 scopus 로고    scopus 로고
    • Zeppo1 is a novel metastasis promoter that represses E-cadherin expression and regulates p120-catenin isoform expression and localization
    • Slorach EM, Chou J, Werb Z. Zeppo1 is a novel metastasis promoter that represses E-cadherin expression and regulates p120-catenin isoform expression and localization. Genes Dev. 2011; 25: 471-484.
    • (2011) Genes Dev , vol.25 , pp. 471-484
    • Slorach, E.M.1    Chou, J.2    Werb, Z.3
  • 35
    • 84861974512 scopus 로고    scopus 로고
    • The PRDM family: expanding roles in stem cells and development
    • Hohenauer T, Moore AW. The PRDM family: expanding roles in stem cells and development. Development. 2012; 139: 2267-2282.
    • (2012) Development , vol.139 , pp. 2267-2282
    • Hohenauer, T.1    Moore, A.W.2
  • 36
    • 84901190070 scopus 로고    scopus 로고
    • PRDM14: a unique regulator for pluripotency and epigenetic reprogramming
    • Nakaki F, Saitou M. PRDM14: a unique regulator for pluripotency and epigenetic reprogramming. Trends Biochem Sci. 2014; 39: 289-298.
    • (2014) Trends Biochem Sci , vol.39 , pp. 289-298
    • Nakaki, F.1    Saitou, M.2
  • 37
    • 35448972855 scopus 로고    scopus 로고
    • Gene amplification and overexpression of PRDM14 in breast cancers
    • Nishikawa N, Toyota M, Suzuki H, et al. Gene amplification and overexpression of PRDM14 in breast cancers. Cancer Res. 2007; 67: 9649-9657.
    • (2007) Cancer Res , vol.67 , pp. 9649-9657
    • Nishikawa, N.1    Toyota, M.2    Suzuki, H.3
  • 38
    • 57049188396 scopus 로고    scopus 로고
    • The zinc finger SET domain gene PRDM14 is overexpressed in lymphoblastic lymphomas with retroviral insertions at Evi32
    • Dettman EJ, Justice MJ. The zinc finger SET domain gene PRDM14 is overexpressed in lymphoblastic lymphomas with retroviral insertions at Evi32. PLoS One. 2008; 3: e3823.
    • (2008) PLoS One , vol.3
    • Dettman, E.J.1    Justice, M.J.2
  • 39
    • 77954242252 scopus 로고    scopus 로고
    • Molecular profiling of invasive breast cancer by multiplex ligation-dependent probe amplification-based copy number analysis of tumor suppressor and oncogenes
    • Moelans CB, de Weger RA, Monsuur HN, et al. Molecular profiling of invasive breast cancer by multiplex ligation-dependent probe amplification-based copy number analysis of tumor suppressor and oncogenes. Mod Pathol. 2010; 23: 1029-1039.
    • (2010) Mod Pathol , vol.23 , pp. 1029-1039
    • Moelans, C.B.1    de Weger, R.A.2    Monsuur, H.N.3
  • 40
    • 84871537455 scopus 로고    scopus 로고
    • Mouse lymphoblastic leukemias induced by aberrant Prdm14 expression demonstrate widespread copy number alterations also found in human ALL
    • Simko SJ, Voicu H, Carofino BL, et al. Mouse lymphoblastic leukemias induced by aberrant Prdm14 expression demonstrate widespread copy number alterations also found in human ALL. Cancers. 2012; 4: 1050-1066.
    • (2012) Cancers , vol.4 , pp. 1050-1066
    • Simko, S.J.1    Voicu, H.2    Carofino, B.L.3
  • 41
    • 84878721081 scopus 로고    scopus 로고
    • Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14
    • Ruark E, Seal S, McDonald H, et al. Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14. Nat Genet. 2013; 45: 686-689.
    • (2013) Nat Genet , vol.45 , pp. 686-689
    • Ruark, E.1    Seal, S.2    McDonald, H.3
  • 42
    • 78049403613 scopus 로고    scopus 로고
    • Relationship between the expression of PRDM14 in non-small cell lung cancer and the clinicopathologic characteristics
    • Liu B, Zhang S, Hui L, et al. Relationship between the expression of PRDM14 in non-small cell lung cancer and the clinicopathologic characteristics. Zhongguo Fei Ai Za Zhi. 2010; 13: 867-872.
    • (2010) Zhongguo Fei Ai Za Zhi , vol.13 , pp. 867-872
    • Liu, B.1    Zhang, S.2    Hui, L.3
  • 43
    • 84892382521 scopus 로고    scopus 로고
    • High expression of PRDM14 correlates with cell differentiation and is a novel prognostic marker is resected non-small cell lung cancer
    • Zhang T, Meng L, Dong W, et al. High expression of PRDM14 correlates with cell differentiation and is a novel prognostic marker is resected non-small cell lung cancer. Med Oncol. 2013; 30: 605.
    • (2013) Med Oncol , vol.30 , pp. 605
    • Zhang, T.1    Meng, L.2    Dong, W.3
  • 44
    • 79960042810 scopus 로고    scopus 로고
    • Arf6 RalA and BIRC5 protein expression in non small cell lung cancer
    • Knizhnik AV, Kovaleva OB, Laktionov KK, et al. Arf6, RalA and BIRC5 protein expression in non small cell lung cancer. Mol Biol. (Mosk). 2011; 45: 307-315.
    • (2011) Mol Biol. (Mosk). , vol.45 , pp. 307-315
    • Knizhnik, A.V.1    Kovaleva, O.B.2    Laktionov, K.K.3
  • 45
    • 0043025147 scopus 로고    scopus 로고
    • Survivin gene expression in early stage non-small cell lung cancer
    • Falleni M, Pellegrini C, Marchetti A, et al. Survivin gene expression in early stage non-small cell lung cancer. J Pathol. 2003; 200: 620-626.
    • (2003) J Pathol , vol.200 , pp. 620-626
    • Falleni, M.1    Pellegrini, C.2    Marchetti, A.3
  • 46
    • 84863365307 scopus 로고    scopus 로고
    • Prognostic value of survivin in patients with non-small cell lung carcinoma: a systematic review with meta-analysis
    • Zhang LQ, Wang J, Jiang F, et al. Prognostic value of survivin in patients with non-small cell lung carcinoma: a systematic review with meta-analysis. PLos One. 2012; 7: e34100.
    • (2012) PLos One , vol.7
    • Zhang, L.Q.1    Wang, J.2    Jiang, F.3
  • 47
    • 1842790378 scopus 로고    scopus 로고
    • c-Myc as a therapeutic target in cancer
    • Prochownik EV. c-Myc as a therapeutic target in cancer. Expert Rev Anticancer Ther. 2004; 4: 289-302.
    • (2004) Expert Rev Anticancer Ther , vol.4 , pp. 289-302
    • Prochownik, E.V.1
  • 48
    • 84859563192 scopus 로고    scopus 로고
    • Expression of caspase-3 and c-myc in non-small cell lung cancer
    • Yoo J, Kim CH, Song SH, et al. Expression of caspase-3 and c-myc in non-small cell lung cancer. Cancer Res Treat. 2004; 36: 303-307.
    • (2004) Cancer Res Treat , vol.36 , pp. 303-307
    • Yoo, J.1    Kim, C.H.2    Song, S.H.3
  • 49
    • 78549269168 scopus 로고    scopus 로고
    • miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc
    • Chen Z, Zheng H, Guo Y, et al. miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc. J Exp Clin Cancer Res. 2010; 29:151.
    • (2010) J Exp Clin Cancer Res , vol.29 , pp. 151
    • Chen, Z.1    Zheng, H.2    Guo, Y.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.